RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 89,544 Value ($000) $366 Avg Close $4.95 Range $3.81 - $7.18
Q2 2025
Shares 633,403 Value ($000) $3,205 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 60,906 Value ($000) $322 Avg Close $7.29 Range $5.19 - $12.36
Q1 2024
Shares 61,963 Value ($000) $618 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 15,059 Value ($000) $148 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 23,707 Value ($000) $181 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 11,845 Value ($000) $88 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 202,898 Value ($000) $1,353 Avg Close $7.93 Range $6.40 - $9.73